Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOS1 | Q07889 | 1/20 | 0.75 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.69 |
| ▸ | PTGS1 | P23219 | 6/20 | 0.69 |
| ▸ | CA2 | P00918 | 10/20 | 0.67 |
| ▸ | CA1 | P00915 | 8/20 | 0.67 |
| ▸ | CA9 | Q16790 | 8/20 | 0.64 |
| ▸ | CA12 | O43570 | 6/20 | 0.64 |
| ▸ | CA7 | P43166 | 4/20 | 0.64 |
| ▸ | CA4 | P22748 | 3/20 | 0.64 |
| ▸ | MAOA | P21397 | 2/20 | 0.64 |
| ▸ | MAOB | P27338 | 1/20 | 0.62 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | CA6 | P23280 | 1/20 | 0.59 |
| ▸ | CA5A | P35218 | 1/20 | 0.59 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | AGO2 | Q9UKV8 | 1/20 | 0.59 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31527705 | 1.00 | SOS1 (0.75) | SOS1PTGS2PTGS1CA2CA1 | |
| SCHEMBL8043459 | 0.97 | SOS1 (0.72) | SOS1PTGS2PTGS1CA2CA1 | |
| Hydrochloric Acid SCHEMBL29876112 | 0.97 | SOS1 (0.72) | SOS1PTGS2PTGS1CA2CA1 | |
| Iodide SCHEMBL28540305 | 0.97 | SOS1 (0.72) | SOS1PTGS2PTGS1CA2CA1 | |
| SCHEMBL1430142 | 0.93 | CA2 (0.76) | SOS1PTGS2PTGS1CA2CA1 | |
| SCHEMBL28385356 | 0.91 | SOS1 (0.64) | SOS1PTGS2PTGS1CA2CA1 | |
| Sulfanilamide SCHEMBL27994963 | 0.91 | CA2 (0.77) | SOS1PTGS2PTGS1CA2CA1 | |
| SCHEMBL27510169 | 0.87 | SOS1 (1.00) | SOS1PTGS2PTGS1CA2CA1 | |
| SCHEMBL202948 | 0.85 | CA2 (0.81) | CA2CA1CA9CA12CA7 | |
| Benzenesulfonamide SCHEMBL28328141 | 0.85 | PTGS2 (0.65) | SOS1PTGS2PTGS1CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4660182-A1 | NAV1.7- AND/OR NAV1.8-INHIBITING ARYL PYRIDINE COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS | Eurofarma Laboratórios S.A. (BR) | 2025-12-10 | — | — | EP | claimed |
| CN-120127231-A | Composite solid electrolyte with carbon fluoride nitride as filler, and preparation method and application thereof | 陕西科技大学 | 2025-06-10 | — | — | CN | claimed |
| CN-120091742-A | Preparation method for effectively reducing defects of perovskite solar cell body | 南开大学 | 2025-06-03 | — | — | CN | claimed |
| CN-119695270-A | Polymer solid electrolyte based on single ion conductor and preparation method thereof | 陕西科技大学 | 2025-03-25 | — | — | CN | claimed |
| CN-119528773-A | N-alkylation method of sulfonamide compound | 赣南医科大学 | 2025-02-28 | — | — | CN | claimed |
| CN-119219810-A | Ionic polymer and preparation method and application thereof | 佛山绿动氢能科技有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-118994036-A | Synthesis method of quinazolinone derivative | 常州大学 | 2024-11-22 | — | — | CN | claimed |
| CN-118507836-B | Electrolyte for secondary lithium metal battery | 深圳欣界能源科技有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-118507836-A | Electrolyte for secondary lithium metal battery | 深圳欣界能源科技有限公司 | 2024-08-16 | — | — | CN | claimed |
| WO-2024159285-A1 | NAV1.7- AND/OR NAV1.8-INHIBITING ARYL PYRIDINE COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS | EUROFARMA LABORATÓRIOS S.A. (BR) | 2024-08-08 | — | — | WO | claimed |
| EP-1150979-A1 | HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2001-11-07 | — | — | EP | claimed |
| US-20010031781-A1 | Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors | ILLIG CARL R (US) | 2001-10-18 | — | — | US | claimed |
| WO-2000076519-A1 | SULFONAMIDE AND SULFAMIDE SUBSTITUTED IMIDAZOQUINOLINES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-12-21 | — | — | WO | claimed |
| EP-1054886-A1 | HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS, IN PARTICULAR AS UROKINASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2000-11-29 | — | — | EP | claimed |
| WO-2000047578-A1 | HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2000-08-17 | — | — | WO | claimed |
| WO-1999040088-A1 | HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS, IN PARTICULAR AS UROKINASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 1999-08-12 | — | — | WO | claimed |
| US-5686492-A | NMR DIAGNOSTIC AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-11-11 | — | — | US | claimed |
| EP-0799197-A1 | DISUBSTITUTED P-FLUOROBENZOLSULFONAMIDES AND THEIR USE IN NMR DIAGNOSTICS | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-10-08 | — | — | EP | claimed |
| WO-1996019447-A1 | DISUBSTITUTED P-FLUOROBENZOLSULFONAMIDES AND THEIR USE IN NMR DIAGNOSTICS | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-06-27 | — | — | WO | claimed |
| CN-1117291-A | 4-Hydroxy-pyran-2-one derivatives for the treatment of retroviral infections | UPJOHN CO (US) | 1996-02-21 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010031781-A1 | Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors | SERPINE1, PRSS3, PRSS2 | SOS1 1987/4885PTGS2 2444/4885PTGS1 1208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.